DARE
NASDAQ · Pharmaceuticals
Dare Bioscience Inc
$2.75
-0.16 (-5.50%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+49.8% upside
Low Target
$2.96
Average Target
$4.12
High Target
$5.49
Current Price
$2.75
Current
$2.75
$2.75
Target
$4.12
$4.12
$2.96
$4.12 avg
$5.49
Scenario Analysis
Bear Case
$2.96
7.6%
Low target
Base Case
$4.12
+49.8%
Avg target
Bull Case
$5.49
+99.6%
High target
Risk/Reward
13.0x
Highly favorable
Price in Context
52-Week High
$9.19
-70.1% from high
52-Week Low
$1.27
+116.5% from low
Target vs 52W High
$4.12
-55.2% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.30
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals